Lv2
170 积分 2024-12-30 加入
All patients with AML and FLT3/ITD should be transplanted in first remission. Also in the era of tyrosine kinase inhibitors? – the PRO
4个月前
已关闭
Impact of clinical characteristics and genetic profiles on outcomes of allogeneic stem cell transplantation with sorafenib maintenance in FLT3-ITD AML patients: A multi-center, retrospective study
4个月前
已完结
Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia: Who, When, and How?
10个月前
已完结
Superior GVHD‐Free, Relapse‐Free Survival for Haploidentical Transplant With PTCy Than Matched Unrelated Donor for AML Patients Transplanted in Second Complete Remission: A Study From the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
11个月前
已完结
皖公网安备34019202002308
